Share on LinkedInShare on LinkedIn

ARTICLE · 28 AUGUST 2025

Key Trends Shaping Life Sciences IP Licensing

Ballard Spahr LLP
Ballard Spahr LLP
Contributor
Ballard Spahr LLP

Ballard Spahr LLP

Ballard Spahr LLP, an AmLaw 100 law firm with 19 US offices, serves clients in more than 50...

View firm profile
Explore more from Ballard Spahr LLP

The life sciences industry continues to evolve rapidly, driven by technological advancements, shifting economic conditions, and global market dynamics.

United StatesIntellectual Property

The life sciences industry continues to evolve rapidly, driven by technological advancements, shifting economic conditions, and global market dynamics. As companies navigate this complex landscape, several key trends are emerging that may have significant legal and business implications. This alert highlights four critical areas that industry participants should closely monitor when negotiating intellectual property licenses: artificial intelligence (AI), tariffs, financings, and manufacturing.

Data and Artificial Intelligence

Data and AI continue to play an increasingly prominent role in the life sciences sector, transforming research, development, and commercialization processes. As life sciences companies continue to create, develop, adapt, and apply data and AI platforms for drug discovery and other life sciences applications, data and AI are also becoming a focal point in licensing and other commercial contracting negotiations. For example, licensors and

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from